相关实验视频

Updated: Jun 12, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

倡导针对性测序查,而不是在21-基酶缺乏症中进行全外体测序

Lavanya Ravichandran¹, Shriti Paul¹, A Rekha²

¹Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.

Indian journal of pediatrics

|September 20, 2024

概括

整体外体序列测定 (WES) 不推用于诊断21-基酶缺乏症 (21-OHD),因为它的准确性很低. 聚焦序列策略 (FSS) 是一种更可靠的方法来识别 21-OHD.中的CYP21A2基因突变.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

整体外基因组测序 (WES) 是孟德尔疾病的常见诊断工具.
涉及CYP21A2基因的21-基酶缺陷 (21-OHD) 的遗传复杂性对WES的适用性提出了挑战.
准确的基因诊断对于管理21-OHD和先天性上腺增生症 (CAH) 至关重要.

研究的目的:

为了评估WES的诊断实用性,与21-OHD的集中顺序策略 (FSS) 相比.
确定WES在检测CYP21A2基因突变中的局限性.
为 21-OHD.确定最佳的遗传检测方法.

主要方法:

对接受WES治疗的患者的病例系列分析.
针对CYP21A2基因热点突变的集中序列策略 (FSS).
针对性测序与先天性上腺增生 (CAH) 相关的基因.
使用多重联结依赖探头放大 (MLPA) 和桑格测序的验证.

主要成果:

与FSS相比,WES显示出高的虚假负率 (6/7) 和一个虚假阳性的21-OHD.比率.
在WES目标缩 (<95%覆盖率) 的限制有助于虚假负面.
CYP21A2基因分析因伪基因重组和基因转换而复杂,影响了WES的准确性.

结论:

由于准确度的显著限制,不建议WES作为21-OHD的主要诊断方法.
针对性测序和基因型测定对检测CYP21A2突变,特别是伪基因衍生的突变更有效.
在有针对性的方法排除CYP21A2突变后,可以考虑WES用于罕见的CAH形式.

关键词:

在CYP21A2中.缺少21-基酶的情况遗传性上腺增生症遗传性上腺增生症整个外基因组的测序.

更多相关视频

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

相关概念视频

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...